Cholestatic hepatitis after liver transplantation is associated with persistently high serum hepatitis C virus RNA levels

Liver Transplantation and Surgery

Volumn 4, Issue 1, 1998, Pages 15-21

  Doughty, A L ^a   Spencer, J D ^a   Cossart, Y E ^a   McCaughan, G W ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; VIRUS RNA;

ADULT; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CHOLESTATIC HEPATITIS; CLINICAL ARTICLE; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GENOTYPE; GRAFT REJECTION; HEPATITIS C VIRUS; HUMAN; LIVER INJURY; LIVER TRANSPLANTATION; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECURRENT VIRUS INFECTION; VIRUS LOAD;

EID: 0031973149     PISSN: 10743022     EISSN: None     Source Type: Journal    
DOI: 10.1002/lt.500040102     Document Type: Article

References (31)

1. 1 Wright TL, Donegan E, Hsu HH, Ferrell L, Lake JR, Kim M, et al. Recurrent and acquired hepatitis C viral infection in liver transplant recipients. Gastroenterology 1992 ; 103: 317–322. MEDLINE
2. 2 Konig V, Bauditz J, Lobeck H, Lusebrink R, Neuhaus P, Blumhardt G, et al. Hepatitis C virus reinfection in allografts after orthotopic liver transplantation. Hepatology 1992 ; 16: 1137–1143. MEDLINE
3. 3 Marzano A, Smedile A, Abate M, Ottobrelli A, Brunetto M, Negro F, et al. Hepatitis type C after orthotopic liver transplantation: reinfection and disease recurrence. J Hepatol 1994 ; 21: 961–965. MEDLINE
4. 4 Gretch DR, Bacchi CE, Corey L, dela Rosa C, Lesniewski R, Kowdley K, et al. Persistent hepatitis C virus infection after liver transplantation: clinical and virological features. Hepatology 1995 ; 22: 1–9. MEDLINE
5. 5 McCaughan GW, Pau A, Parsons C, McGuinness PH, Gallagher ND, Sheil AG. Hepatitis C infection in liver transplant patients. Transplant Proc 1992 ; 24: 2256. MEDLINE
6. 6 Muller H, Otto G, Goeser T, Arnold J, Pfaff E, Theilmann L. Recurrence of hepatitis C virus infection after orthotopic liver transplantation. Transplantation 1992 ; 54: 743–745. MEDLINE
7. 7 Arnold JC, Kraus T, Otto G, Muller HM, Hofmann W, Gmelin K, et al. Recurrent hepatitis C virus infection after liver transplantation. Transplant Proc 1992 ; 24: 2646–2647. MEDLINE
8. 8 Sallie R, Cohen AT, Tibbs CJ, Portmann BC, Rayner A, O'Grady JG, et al. Recurrence of hepatitis C following orthotopic liver transplantation: a polymerase chain reaction and histological study. J Hepatol 1994 ; 21: 536–542. MEDLINE
9. 9 Feray C, Gigou M, Samuel D, Paradis V, Wilber J, David MF, et al. The course of hepatitis C virus infection after liver transplantation. Hepatology 1994 ; 20: 1137–1143. MEDLINE
10. 10 Schluger LK, Sheiner PA, Thung SN, Lau JYN, Min A, Wolf DC, et al. Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation. Hepatology 1996 ; 23: 971–976. MEDLINE
11. 11 Dickson RC, Caldwell SH, Ishitani MB, Lau JYN, Driscoll CJ, Stevenson WC, et al. Clinical and histologic patterns of early graft failure due to recurrent hepatitis C in four patients after liver transplantation. Transplantation 1996 ; 61: 701–705. MEDLINE
12. 12 Chazouilleres O, Kim M, Combs C, Ferrell L, Bacchetti P, Roberts J, et al. Quantitation of hepatitis C virus RNA in liver transplant recipients. Gastroenterology 1994 ; 106: 994–999. MEDLINE
13. 13 Duvoux C, Pawlotsky JM, Cherqui D, Tran van Nhieu J, Metreau JM, Fagniez PL, et al. Serial quantitative determination of hepatitis C virus RNA levels after liver transplantation. A useful test for diagnosis of hepatitis C virus reinfection. Transplantation 1995 ; 60: 457–461. MEDLINE
14. 14 Gane EJ, Naoumov NV, Qian KP, Mondelli MU, Maertens G, Portmann BC, et al. A longitudinal analysis of hepatitis C virus replication following liver transplantation. Gastroenterology 1996 ; 110: 167–177. MEDLINE
15. 15 Feray C, Gigou M, Samuel D, Paradis V, Mishiro S, Maertens G, et al. Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation. Gastroenterology 1995 ; 108: 1088–1096. MEDLINE
16. 16 Roth WK, Lee JH, Ruster B, Zeuzem S. Comparison of two quantitative hepatitis C virus reverse transcriptase PCR assays. J Clin Micro 1996 ; 34: 261–264.
17. 17 Chomczynski P, Sacchi N. Single‐step method of RNA isolation by acid guanidinium thiocyanate‐phenol‐chloroform extraction. Anal Biochem 1987 ; 162: 156–159. MEDLINE
18. 18 McGuinness PH, Bishop GA, Lien A, Wiley B, Parsons C, McCaughan GW. Detection of serum hepatitis C virus RNA in HCV antibody seropositive volunteer blood donors. Hepatology 1993 ; 18: 485–490. MEDLINE
19. 19 McGuinness PH, Bishop GA, Painter DM, Chan R, McCaughan GW. Intrahepatic hepatitis C RNA levels do not correlate with degree of liver injury in patients with chronic hepatitis C. Hepatology 1996 ; 23: 676–687. MEDLINE
20. 20 Enomoto N, Takada A, Nakao T, Date T. There are two major types of hepatitis C virus in Japan. Biochem Biophys Res Comm 1990 ; 170: 1021–1025. MEDLINE
21. 21 Chan SW, McOmish F, Holmes EC, Dow B, Peutherer JF, Follett E, et al. Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants. J Gen Virol 1992 ; 73: 1131–1141. MEDLINE
22. 22 Simmonds P, Holmes EC, Cha TA, Chan SW, McOmish F, Irvine B, et al. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS 5 region. J Gen Virol 1993 ; 7411: 2391–2399.
23. 23 Lis JT. Fractionation of DNA fragments by polyethylene induced precipitation. Methods Enzymol 1980 ; 65: 347–353. MEDLINE
24. 24 Shiffman ML, Contos MJ, Luketic VA, Sanyal AJ, Purdum PP, Mills AS, et al. Biochemical and histologic evaluation of recurrent hepatitis C following orthotopic liver transplantation. Transplantation 1994 ; 57: 526–532. MEDLINE
25. 25 Hoffmann RM, Gunther C, Diepolder HM, Zachoval R, Eissner HJ, Forst H, et al. Hepatitis C virus infection as a possible risk factor for ductopenic rejection (vanishing bile duct syndrome) after liver transplantation. Transplant Intl 1995 ; 8: 353–359.
26. 26 Davies SE, Portmann BC, O'Grady JG, Aldis PM, Chaggar K, Alexander GJ, et al. Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis. Hepatology 1991 ; 13: 150–157. MEDLINE
27. 27 Napoli J, Bishop GA, McGuinness PH, Painter DM, McCaughan GW. Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1 associated cytokines. Hepatology 1996 ; 24: 759–765. MEDLINE
28. 28 Guidotti LG, Ishikawa T, Hobbs MV, Matzke B, Schreiber R, Chisari FV. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 1996 ; 4: 25–36. MEDLINE
29. 29 Gretch D, Corey L, Wilson J, dela Rosa C, Wilson R, Carithers R, et al. Assessment of hepatitis C virus RNA levels by quantitative competitive RNA polymerase chain reaction: high titer viremia correlates with advanced stage of disease. J Infect Dis 1994 ; 169: 1219–1225. MEDLINE
30. 30 Freeman RB, Tran S, Lee YM, Rohrer RJ, Kaplan MM. Serum hepatitis C RNA titers after liver transplantation are not correlated with immunosuppression or hepatitis. Transplantation 1996 ; 61: 542–546. MEDLINE
31. 31 Lim HL, Lay GKK, Davis GL, Dolson DJ, Lau JYN. Cholestatic hepatitis leading to hepatic failure in a patient with organ‐transmitted hepatitis C virus infection. Gastroenterology 1994 ; 106: 248–251. MEDLINE